Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher

Author: Avi Kapoor | March 04, 2024 03:34pm

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday.

The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell, dropping, 0.01% to 5,137.05.

Check This Out: Top 4 Tech Stocks That May Implode This Month

 

Leading and Lagging Sectors

 

Utilities shares rose by 0.9% on Monday.

In trading on Monday, communication services shares fell by 1.6%.

 

Top Headline

 

Super Micro Computer, Inc. (NASDAQ:SMCI) will join the S&P 500 Index, effective March 18, S&P Dow Jones Indices, a division of S&P Global, said in a release. Deckers Outdoor Corporation (NASDAQ:DECK) will replace Zions Bancorporation (NASDAQ:ZION) in the S&P 500.

 

Equities Trading UP

 

Cardiff Oncology, Inc. (NASDAQ:CRDF) shares shot up 16% to $3.3862 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.

Shares of Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) got a boost, surging 23% to $3.4550 after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.

Renalytix Plc (NASDAQ:RNLX) shares were also up, gaining 27% to $1.3250 after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.

 

Equities Trading DOWN

 

BioVie Inc. (NASDAQ:BIVI) shares dropped 43% to $1.0850 after the company reported pricing of public offering.

Shares of BioCardia, Inc. (NASDAQ:BCDA) were down 21% to $0.4599 after reporting interim results from Phase III CardiAMP cell therapy heart failure trial.

JOANN Inc. (NASDAQ:JOAN) was down, falling 42% to $0.2937 following a Bloomberg report stating the company is contemplating a bankruptcy filing to restructure its debt and regain financial stability.

Also Check This Out: 'I Think You've Got An Interesting Stock Here': Cramer On This Advertising Company

 

Commodities

 

In commodity news, oil traded down 1.5% to $78.72 while gold traded up 1.5% at $2,126.00.

Silver traded rose 2.7% to $23.99 on Monday while copper fell 0.2% to $3.8530.

 

Euro zone

 

European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.03%, London’s FTSE 100 fell 0.55% while Spain’s IBEX 35 Index rose 0.05% The German DAX declined 0.11% French CAC 40 rose 0.28% while Italy’s FTSE MIB Index fell 0.07%.

The number of people registering as jobless in Spain declined by 0.3% to 2.76 million in February.

 

Asia Pacific Markets

 

Asian markets closed higher on Monday, with Japan’s Nikkei 225 gaining 0.50%, Hong Kong’s Hang Seng Index climbing 0.04%, China’s Shanghai Composite Index gaining 0.41% and India’s S&P BSE Sensex gaining 0.2%.

Singapore’s manufacturing PMI slipped to 50.6 in February from 50.7 in the prior month.

 

Economics

 

No economic report of significance is due for Monday.

Now Read This: How To Earn $500 A Month From Nordstrom Stock Ahead Of Q4 Earnings Report

Posted In: BCDA BIVI CRDF DECK JOAN QNRX RNLX SMCI ZION

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist